Skip to main content
Profile picture for Jack Cush, MD

Jack Cush, MD

Dr. Cush is the Executive Editor of RheumNow.com and also Co-Edits the online textbook RheumaKnowledgy.com. 
  
Dr. Cush's interests include medical education, novel drug development, rheumatoid arthritis, spondyloarthritis, drug safety, and Still's disease/autoinflammatory syndromes. He has published over 140 articles and 2 books in rheumatology.
 
He can be followed on twitter: @RheumNow

Articles By Jack Cush, MD

janefingr.JPG

Sildenafil May Help Heal Scleroderma Ulcers

A prospective study of sildenafil was conducted in 25 centers that included 83 patients and 192 digital ulcers at entry. The odds of healing ulcers was less, but not significant, for sildenafil.

Read Article
Hand.LC_.jpg

RA Sarilumab Trials Meet Primary Endpoints

Three phase III studies of sarilumab (SARIL-RA-TARGET, -EASY and -ASCERTAIN), a fully-human IL6 receptor antibody, have been reported and met primary end points in these pivotal clinical trials.

Read Article
inflammation.jpg

Inflammatory Fibromyalgia - Is it Possible?

Fibromyalgia is a noninflammatory disorder. However, there are patients with prolonged morning stiffness, subjective joint swelling and many with modest-to-moderate elevations of acute-phase reactants.

Read Article
DXA1.jpg (keep)

Underuse & Overuse of DXA Screening

A US Preventive Services Task Force recommends DEXA screening in women >65 yrs and only in women 65 yrs if there is a significan risk of fracture.  Amarnath and coworkers studied 50,995 women in primary care, aged 40-85 years, between 2006-2012.

Read Article
injection_1.jpg

Amgen & Abbvie Increase the Price of TNF Inhibitors

The manufacturers of the 2 best selling TNF inhibitors, Enbrel and Humira, have announced a 9.9% price increase of May 1st. The current average price of Enbrel is $42,000 per annum.

Read Article
230px-Sjogren_syndrome_%282%29.jpg

The Real Prevalence of Sjogren's Syndrome

The population prevalence of Sjogrens syndrome is  0.2%, with an incidence of 4 cases per 100,000 per year.  Sjogrens is 20 times more common in females than males.

Read Article
microneedlepill.jpg

A Microneedle Pill as an Alternative to Injectable Drug

Carl Schoellhammerhas just won the Lemelson-MIT National Collegiate Student Prize for his invention - the microneedle pill.

Read Article

Rheumatology Pearls from Twitter - Really?

To many of my colleagues (admitted Luddites) the mere mention of Twitter results in the “omi-god 360” eye roll with an accompanying snide comment.

Read Article
dryeyes.jpg

Sjogrens Syndrome and Familial Risk

A population based study from Taiwan shows that Sjogren's syndrome, to have a prevalence of 0.05%. The prevalence of the syndrome, however, was 10 times higher among women (0.10%) compared to men (0.01%). Overall, having an affected first-degree relative with Sjogren's syndrome carried

Read Article
×